Vactosertib

未知生产厂商

Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).

技术标识符

化学式: C₂₂H₁₈FN₇
CAS 编号: 1352608-82-2
UNII ID: 6T4O391P5Y

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Application of nicotinamide compounds in preparation of medicine for treating and resisting chordoma
CN 112843058 A申请人: HUASHAN HOSPITAL FUDAN UNIV优先权: 2021
CN
Application of formamide compound in preparation of drug for resisting spinal cord tumor and kit
CN 112851695 A申请人: HUASHAN HOSPITAL FUDAN UNIV优先权: 2021
CN
Vactosertib or linivonib and application of combination of Vactosertib and linivonib in preparation of medicine for treating asthma
CN 118976025 A申请人: UNIV CHINA PHARMA优先权: 2024
CN
TGF-BETA RECEPTOR INHIBITORS FOR USE IN THE THERAPEUTIC TREATMENT OF A PULMONARY FIBROTIC DISEASE
WO 2026104985 A1申请人: A D A S R L优先权: 2024
WO

药物